The leaders of data and analytics venture Trilliant Health on Tuesday said they have completed their Series A raise at $12 million and recruited an Atlanta firm with plenty of Nashville-area ties to lead it.
Trilliant — which markets various growth, strategy and marketing services to hospitals and was formed last year via the merger of Clariture and Aegis Health — early this year announced it had secured an undisclosed amount of backing from Nashville Capital Network, Martin Ventures, Jon Phillips of First Trust Capital and some of its own executives. Since then, Atlanta-based Noro-Moseley Partners and local angel capital group NueCura Partners joined NCN and Martin Ventures to contribute another $7 million.
The funding will go toward a further buildout of Trilliant’s data science and technology. In all, the company now employs about 80 people, up from about 50 at the end of 2017. From its base in Maryland Farms’ Creekside Crossing development, CEO Hal Andrews and his team work with more than 60 health systems across the country, seeking to turn masses of marketing, claims and demographic data into information hospital leaders can use to decide where to build new facilities and how to better work with their insurers, doctors and employers.
“The Trilliant leadership team and investor group have some of the strongest backgrounds and expertise in health care,” said Spence McClelland, general partner at Noro-Moseley. “This health care experience, combined with the deep bench of data science, technology, and product teams, positions Trilliant to transform the way health care systems approach growth.”
Noro-Moseley’s history in Middle Tennessee dates back many years and includes names such as the former Surgical Alliance, BioMimetic Pharmaceuticals and NeoSpine. More recently, the firm also put money into the original Change Healthcare and home hospitalization venture Contessa Health.